Published in Lab Business Week, June 11th, 2006
For the period ended March 31, 2006, Alexion reported revenues of $0.8 million and a net loss of $27.2 million, resulting in a basic and diluted loss per share of $0.88.
For the period ended March 31, 2006, the company reported revenues of $0.8 million compared to $0.6 million for the same period last year. Compared to last year, the company had increased activity related to government funded research grants.
Total reported operating expenses for the 3-month period ended March 31, 2006 were $29.4 million. This compares to...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.